Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor

An isolated 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 or 26908 nucleic acid molecule selected from the group consisting of:

• a) a nucleic acid molecule comprising a nucleotide sequence which is at least 60% identical to the nucleotide sequence of SEQ ID NO:
• 1, 3, 29, 31, 69, 71, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 103 or 105;
• b) a nucleic acid molecule comprising a fragment of at least 15 nucleotides of the nucleotide sequence of SEQ ID NO:
• 1, 3, 29, 31, 69, 71, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 103 or 105;
• c) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:
• 2, 30, 70, 78, 81, 84, 87, 90, 93 or 104;
• d) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of SEQ ID NO:
• 2, 30, 70, 78, 81, 84, 87, 90, 93 or 104, wherein the fragment comprises at least 15 contiguous amino acids of SEQ ID NO:
• 2, 30, 70, 78, 81, 84, 87, 90, 93 or 104;
• e) a nucleic acid molecule which encodes a naturally occurring allelic variant of a polypeptide comprising the amino acid sequence of SEQ ID NO:
• 2, 30, 70, 78, 81, 84, 87, 90, 93 or 104, wherein the nucleic acid molecule hybridizes to a nucleic acid molecule comprising SEQ ID NO:
• 1, 3, 29, 31, 69, 71, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 103 or 105, or a complement thereof, under stringent conditions;
• f) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:
• 1, 3, 29, 31, 69, 71, 77, 79, 80, 82, 83, 85, 86, 88, 89, 91, 92, 94, 103 or 105;
• and
• g) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:
• 2, 30, 70, 78, 81, 84, 87, 90, 93 or 104.